Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.990
+0.110 (5.85%)
At close: Mar 9, 2026, 4:00 PM EDT
1.950
-0.040 (-2.01%)
After-hours: Mar 9, 2026, 7:50 PM EDT
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $136.05 million as of March 9, 2026. Its market cap has decreased by -43.38% in one year.
Market Cap
136.05M
Enterprise Value
78.57M
1-Year Change
-43.38%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $136.05M, an increase of 142.94%. That is a compound annual growth rate of 6.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 128.50M | -32.12% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |
| Adagene | 133.85M |
| Oramed Pharmaceuticals | 130.75M |
| Polaryx Therapeutics | 129.72M |
| Spero Therapeutics | 129.58M |
| Aardvark Therapeutics | 127.37M |
| Alpha Cognition | 125.89M |